🦊/Investors

Excel Venture ManagementFull Portfolio

33 tracked investments · listed companies and verified rows first

Aileron Therapeuticsreintx.cominNASDAQ: RNTXDec 2016

Aileron Therapeutics is a clinical-stage biopharmaceutical company developing peptide and protein-based therapies for rare lung and fibrosis diseases.

BiotechCambridge, US

Manuel Aivado(Executive Officer)inBrian Windsor(President and Chief Executive Officer; Director)in

BoardSeth L. Harrison(Director)Reinhard J. Ambros(Director)Joseph A. Yanchik III(Executive Officer, Director)in

Board seatCaleb Winder· per SEC Form D

Co-investorsNovartis Venture Fund

NeuroBo Pharmaceuticalsmetaviatx.comNASDAQ: MTVAMar 2017SEC filingmedium confidence

MetaVia is a clinical-stage biotechnology company developing therapeutics for cardiometabolic diseases, including DA-1726 for obesity and vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

BiotechHealthtechCambridge, US

Mina Sooch(Executive Officer)Hyung Heon Kim(Executive Officer, Director)Margaret McShane(Executive Officer)David Lowenschuss(Executive Officer)Marshall Woodworth(Chief Financial Officer)Charles Bisgaier(Executive Officer)

Board seatSteve Gullans· per SEC Form D · $12.5M raise · filed Mar 2017

Co-investorsGREAT LAKES BAY VENTURE

Agilentagilent.cominNYSE: A

Agilent manufactures laboratory instruments, software, reagents, and consumables for pharmaceutical, diagnostics, clinical research, and applied markets including chemicals, food, and environmental sectors.

William Redington HewlettPadraig McDonnell(President and Chief Executive Officer)in

Co-investorsCalifornia Technology VenturesCatalyst Health VenturesLAV

ClearDATAcleardata.comin𝕏✓ verified

ClearDATA is a cloud security and compliance platform purpose-built for healthcare organizations.

Cloud ComputingCybersecurityDigital HealthHealthtech

Rick Froehlich(President & Chief Executive Officer)inJim Ducharme(Chief Technology Officer)inGregg Bjork(Chief Revenue Officer)inDrew Schaal(Chief Financial Officer)inCarol Boone(Vice President of People)in

Co-investorsFlare Capital PartnersNorwest Venture PartnersMerck Global Health Innovation FundHLM Venture Partners

Qstreamqstream.comin𝕏✓ verified

Qstream offers a microlearning platform with AI tools that turn existing content into short, scenario-based training courses.

AI & Machine LearningEdTechSaaSBurlington, US

Duncan Lennox(Executive Officer, Director, Promoter)inBranch Price Kerfoot(Director)

BoardHambleton Lord(Director)inShay Garvey(Director)inGaye Bok(Director)Harold Copperman(Director)

Co-investorsDelta PartnersLaunchpad Venture GroupEnterprise IrelandBantam GroupFrontline VenturesPolaris Partners

Censinetcensinet.cominJan 2023SEC filingmedium confidence

Censinet provides risk management solutions for healthcare organizations, built by former healthcare operators and security experts who understand the integrated risks healthcare systems face.

CybersecurityEnterprise SoftwareHealthtechSaaSBoston, US

Ed Gaudet(Founder)inCambrey Warein

Board seatCaleb Winder· per SEC Form D · $9M raise · filed Jan 2023

Co-investorsBallad VenturesExcelerate Health VenturesHLM Venture PartnersMemorialCare Innovation FundSchooner CapitalLRVHealth+1 more

Infobionicinfobionic.comOct 2023

InfoBionic.Ai develops a remote cardiac monitoring platform called MoMe ARC that combines AI-powered ECG analysis, interchangeable biosensors, and clinical analytics to enable hospital-grade cardiac telemetry outside traditional hospital settings.

AI & Machine LearningHealthtechMedical DevicesLowell, US

Steven Wasserman(Executive Officer)Nancy Briefs(Executive Officer, Director)

BoardCarl Berke(Director)Al Wiegman(Director)Hamid Tabatabaie(Director)

Board seatCaleb Winder· per SEC Form D

Co-investorsBroadview VenturesHealthtech CapitalKeiretsu Forum

Neosensoryneosensory.comDec 2018

Houston, US

David Eagleman(Executive Officer, Director)Scott Novich(Executive Officer, Director)

BoardJon Callaghan(Director)in

Board seatJuan Enriquez· per SEC Form D

Co-investorsHCVCWestern Technology InvestmentDigiTx Partners LLCTrue Ventures

WellDocwelldoc.comin𝕏Dec 2015

Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions.

AI & Machine LearningDigital HealthHealthtechBaltimore, US

Ryan Sysko(Executive Officer, Director)inSuzanne Clough(Executive Officer)inKevin McRaith(President and CEO)inAnand Iyer(Chief AI Officer)inChris Bergstrom(Executive Officer)in

BoardTerry Lierman(Director)

Board seatJuan Enriquez· per SEC Form D

Co-investorsMerck Global Health Innovation FundSamsung VenturesAsset Management CompanyDigiTx Partners LLCTCP Venture CapitalWindham Capital Partners+1 more

Aileronrxaileronrx.comin
Awarixmckesson.comin𝕏

McKesson distributes pharmaceuticals and medical supplies to pharmacies, hospitals, doctors' offices and clinics across North America, and provides technology and services covering specialty and cancer care, medication access and affordability, and pharmacy financial support.

Digital HealthHealthtechLogistics & Supply Chain

Co-investorsNew Capital Partners

Cleveland HeartLabclevelandheartlab.com𝕏Jun 2014

Cleveland HeartLab provides diagnostic blood tests that use a multimarker approach, including inflammatory biomarkers such as hsCRP and MPO, to assess and stratify an individual's cardiovascular disease risk.

BiotechDigital HealthHealthtechCleveland, US

Rebecca Holland(Executive Officer)Pamela Gornall(Executive Officer)Jacob Orville(Executive Officer, Director)

BoardSteve Gullans(Director)William Cadogan(Director)Gus Lawlor(Director)

Co-investorsMutual Capital PartnersAdvantage Capital PartnersHealthCare Ventures, LLC

Decisionresourcesgroupdecisionresourcesgroup.comin𝕏

Decision Resources Group (now Clarivate) provides data and solutions spanning the healthcare ecosystem to help clients make informed decisions.

Data & InfrastructureDigital HealthEnterprise SoftwareHealthtech

Illuminossilluminoss.comAcquired

IlluminOss Medical makes a light-curable, patient-conforming intramedullary implant for minimally invasive fracture repair.

Co-investorsLongwood FundSlater Technology Fund

Intact Vascularphilips.comin𝕏

Philips develops health technology and consumer products for patients, healthcare providers, and households, with an emphasis on durable, recyclable products.

Circular EconomyConsumerHealthtechMedical DevicesAmsterdam, NL

Co-investorsNew Enterprise Associates (NEA)Sanderling Ventures

Meetzipongomeetzipongo.comin
Molecular Templatesin

BiotechAustin, US

Eric E. Poma(Executive Officer, Director)Jason S. Kim(Executive Officer)David R. Hoffmann(Director)David Hirsch(Director)David Valacer(Executive Officer)Harold Selick(Director)

Co-investorsSante Health Ventures

Open Wateropenwater.healthin𝕏

Openwater develops an imaging platform using two optical modalities designed to diagnose and monitor diseases at the size and cost of a smartphone.

AI & Machine LearningDeep TechHardwareHealthtechMedical DevicesSan Francisco, US

Dr. Mary Lou Jepsen(Executive Chairman & Founder)in

Co-investorsAIR CapitalBold Capital PartnersCollaborative FundLauder PartnersPlum Alley InvestmentsResolute Ventures+3 more

Orionis Biosciencesorionisbio.comin𝕏

Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.

BiotechDeep TechNewton, US

Nikolai Kley(Founder)inNikolai Kley, Ph.D.(Executive Officer, Director)

BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)

Co-investorsSolari CapitalSolasta VenturesV-Bio VenturesWessel Management

Saladax Biomedicalsaladax.comin

Saladax Biomedical develops blood-level tests that help psychiatrists and oncologists determine correct individual drug dosages based on patient metabolism, supporting treatment decisions and reducing toxicity risk.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsLife Sciences Greenhouse InvestmentsGolden Seeds

Shapeshape.com

Shape is a digital wellness media publication offering science-backed articles, product reviews, and expert advice on fitness, health, and wellness.

ConsumerMedia & EntertainmentWellness & FitnessNew York, US

Co-investorsBeechwood CapitalCue Ball

Syntheticgenomicssyntheticgenomics.comin

Synthetic Genomics provides independent reviews and research on online casinos in Canada, focusing on payment methods, licensing, payout speed, and responsible gambling protections rather than promotional bonuses.

Marketplaces

Tetraphase PharmaceuticalsinJan 2020acquired by La Jolla Pharmaceutical Company · Jul 2020 · $43M

Tetraphase Pharmaceuticals was a Watertown, MA biopharmaceutical company developing novel tetracycline antibiotics, including its lead drug Xerava (eravacycline) for multidrug-resistant bacterial infections.

BiotechWatertown, US

Guy Macdonald(Director)inLarry Edwards(Executive Officer, Director)inMaria Stahl(Executive Officer)inChristopher Watt(Executive Officer)

BoardL. Patrick Gage(Director)Keith Maher(Director)

Co-investorsBay City CapitalF-Prime CapitalFlagship VenturesMediphase Venture Partners

Thermo Fisher Scientificthermofisher.comin𝕏Feb 2014Acquired

Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.

BiotechEnterprise SoftwareHardwareHealthtechWaltham, US

Anthony Uzzo(Executive Officer, Director)inJoshua Geballe(Executive Officer, Director)James Gregory(Executive Officer, Director)Marc N. Casper(Executive Officer, Director)inAndrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)

Co-investorsARCH Venture PartnersBayMed Venture PartnersCross Creek AdvisorsHeran PartnersOak HC/FTDomain Associates+2 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Farmer Willie'sShapeUpZipongoAventura HQ, Inc.DnaeGemphireLantos TechnologiesTphaseVirgin Pulse

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.